Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

39 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Treatment of malignant, non-resectable, epithelial origin esophageal tumours with the humanized anti-epidermal growth factor antibody nimotuzumab combined with radiation therapy and chemotherapy.
Ramos-Suzarte M, Lorenzo-Luaces P, Lazo NG, Perez ML, Soriano JL, Gonzalez CE, Hernadez IM, Albuerne YÁ, Moreno BP, Alvarez ES, Callejo IP, Alert J, Martell JA, Gonzalez YS, Gonzalez YS, Astudillo de la Vega H, Ruiz-Garcia EB, Ramos TC. Ramos-Suzarte M, et al. Among authors: astudillo de la vega h. Cancer Biol Ther. 2012 Jun;13(8):600-5. doi: 10.4161/cbt.19849. Epub 2012 Jun 1. Cancer Biol Ther. 2012. PMID: 22555809 Free article. Clinical Trial.
Differential proteomic analysis reveals that EGCG inhibits HDGF and activates apoptosis to increase the sensitivity of non-small cells lung cancer to chemotherapy.
Flores-Pérez A, Marchat LA, Sánchez LL, Romero-Zamora D, Arechaga-Ocampo E, Ramírez-Torres N, Chávez JD, Carlos-Reyes Á, Astudillo-de la Vega H, Ruiz-García E, González-Pérez A, López-Camarillo C. Flores-Pérez A, et al. Among authors: astudillo de la vega h. Proteomics Clin Appl. 2016 Feb;10(2):172-82. doi: 10.1002/prca.201500008. Epub 2015 Sep 14. Proteomics Clin Appl. 2016. PMID: 26175166
A microRNA signature associated with pathological complete response to novel neoadjuvant therapy regimen in triple-negative breast cancer.
García-Vazquez R, Ruiz-García E, Meneses García A, Astudillo-de la Vega H, Lara-Medina F, Alvarado-Miranda A, Maldonado-Martínez H, González-Barrios JA, Campos-Parra AD, Rodríguez Cuevas S, Marchat LA, López-Camarillo C. García-Vazquez R, et al. Among authors: astudillo de la vega h. Tumour Biol. 2017 Jun;39(6):1010428317702899. doi: 10.1177/1010428317702899. Tumour Biol. 2017. PMID: 28621239 Free article.
DNA Repair Proteins as Therapeutic Targets in Ovarian Cancer.
López-Camarillo C, Rincón DG, Ruiz-García E, Astudillo-de la Vega H, Marchat LA. López-Camarillo C, et al. Among authors: astudillo de la vega h. Curr Protein Pept Sci. 2019;20(4):316-323. doi: 10.2174/1389203719666180914091537. Curr Protein Pept Sci. 2019. PMID: 30215333 Review.
MicroRNA-143 is Associated With Pathological Complete Response and Regulates Multiple Signaling Proteins in Breast Cancer.
García-Vázquez R, Marchat LA, Ruíz-García E, Astudillo-de la Vega H, Meneses-García A, Arce-Salinas C, Bargallo-Rocha E, Carlos-Reyes Á, López-González JS, Pérez-Plasencia C, Ramos-Payán R, Aguilar-Medina M, López-Camarillo C. García-Vázquez R, et al. Among authors: astudillo de la vega h. Technol Cancer Res Treat. 2019 Jan 1;18:1533033819827309. doi: 10.1177/1533033819827309. Technol Cancer Res Treat. 2019. PMID: 30755102 Free PMC article.
Effects of omega-3 fatty acids supplementation on neoadjuvant chemotherapy-induced toxicity in patients with locally advanced breast cancer: a randomized, controlled, double-blinded clinical trial.
de la Rosa Oliva F, Meneses García A, Ruiz Calzada H, Astudillo de la Vega H, Bargalló Rocha E, Lara-Medina F, Alvarado Miranda A, Matus-Santos J, Flores-Díaz D, Oñate-Acuña LF, Gutiérrez-Salmeán G, Ruiz García E, Ibarra A. de la Rosa Oliva F, et al. Among authors: astudillo de la vega h. Nutr Hosp. 2019 Aug 26;36(4):769-776. doi: 10.20960/nh.2338. Nutr Hosp. 2019. PMID: 31192682 Free article. Clinical Trial. English.
Comparative proteomic profiling of triple-negative breast cancer reveals that up-regulation of RhoGDI-2 is associated to the inhibition of caspase 3 and caspase 9.
Muñiz Lino MA, Palacios-Rodríguez Y, Rodríguez-Cuevas S, Bautista-Piña V, Marchat LA, Ruíz-García E, Astudillo-de la Vega H, González-Santiago AE, Flores-Pérez A, Díaz-Chávez J, Carlos-Reyes Á, Álvarez-Sánchez E, López-Camarillo C. Muñiz Lino MA, et al. Among authors: astudillo de la vega h. J Proteomics. 2014 Dec 5;111:198-211. doi: 10.1016/j.jprot.2014.04.019. Epub 2014 Apr 22. J Proteomics. 2014. PMID: 24768906
Gastric cancer in Latin America.
Ruíz-García E, Guadarrama-Orozco J, Vidal-Millán S, Lino-Silva LS, López-Camarillo C, Astudillo-de la Vega H. Ruíz-García E, et al. Among authors: astudillo de la vega h. Scand J Gastroenterol. 2018 Feb;53(2):124-129. doi: 10.1080/00365521.2017.1417473. Epub 2017 Dec 23. Scand J Gastroenterol. 2018. PMID: 29275643 Review.
let-7d-3p is associated with apoptosis and response to neoadjuvant chemotherapy in ovarian cancer.
García-Vázquez R, Gallardo Rincón D, Ruiz-García E, Meneses García A, Hernández De La Cruz ON, Astudillo-De La Vega H, Isla-Ortiz D, Marchat LA, Salinas-Vera YM, Carlos-Reyes Á, López-González S, Ramos-Payan R, López-Camarillo C. García-Vázquez R, et al. Among authors: astudillo de la vega h. Oncol Rep. 2018 Jun;39(6):3086-3094. doi: 10.3892/or.2018.6366. Epub 2018 Apr 12. Oncol Rep. 2018. PMID: 29658612
AngiomiRs: MicroRNAs driving angiogenesis in cancer (Review).
Salinas-Vera YM, Marchat LA, Gallardo-Rincón D, Ruiz-García E, Astudillo-De La Vega H, Echavarría-Zepeda R, López-Camarillo C. Salinas-Vera YM, et al. Among authors: astudillo de la vega h. Int J Mol Med. 2019 Feb;43(2):657-670. doi: 10.3892/ijmm.2018.4003. Epub 2018 Nov 27. Int J Mol Med. 2019. PMID: 30483765 Review.
39 results